Vitamin A
FDA-approved product (capsule, oral), marketed as Aquasol A, Vitamin A.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 0 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Acne
- Eye disease
- Nasal congestion
Indications ChEMBL records as approved, from FDA and DailyMed labels.
- WHO therapeutic group
- Vitamin a, plain; Retinoids for topical use in acne; Other nasal preparations; Other ophthalmologicals
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
No supported pathogen reaches ≥40% AI-predicted activity for Vitamin A, so it is not among the repurposing candidates. Its predictions are shown below.
AI-predicted activity
AI prediction · nothing measured- MRSA20.2% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- E. coli32.2% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae13.0% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis36.5% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Vitamin A with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- AsenapineExisting use: Bipolar disorder, Bipolar I disorder, Psychosis and 1 more61.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Donepezil HydrochlorideExisting use: Alzheimer disease, Dementia61.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Mobocertinib SuccinateExisting use: Neoplasm, Non-small cell lung carcinoma61.8% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- BaricitinibExisting use: Rheumatoid arthritis61.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Caspofungin AcetateExisting use: Aspergillosis, Candidemia, Candidiasis and 1 more61.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Ergoloid MesylatesExisting use: Cardiovascular disease61.6% AI-predicted activityagainst M. tuberculosis2 registered studies
- Icatibant AcetateExisting use: Angioedema, Hereditary angioedema61.6% AI-predicted activityagainst M. tuberculosis33 registered studies
- Tenofovir Alafenamide FumarateExisting use: Chronic hepatitis B virus infection, Hepatitis B virus infection, HIV infection and 2 more61.6% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Triptorelin PamoateExisting use: Central precocious puberty, Metastatic prostate cancer, Neoplasm and 3 more61.5% AI-predicted activityagainst M. tuberculosis50+ registered studies
- IloperidoneExisting use: Psychosis, Schizophrenia61.5% AI-predicted activityagainst M. tuberculosis32 registered studies
- Ganirelix AcetateExisting use: Female infertility, Positive regulation of ovulation, Reproductive Techniques, Assisted61.4% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Bazedoxifene AcetateExisting use: Postmenopausal osteoporosis61.4% AI-predicted activityagainst M. tuberculosis50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL
NCT04175587 · start 2019-12-01
Registered record
- Registry ID
- NCT04175587
- Conditions
- Acute Promyelocytic Leukaemia
- Interventions
- Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2019-12-01
- Completion
- 2023-08-31
- Enrolment
- 109
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAcute Promyelocytic LeukaemiaInterventionCompound Realgar-Indigo Naturalis Formula Plus Retinoic AcidPhasePhase 3Registry statusUnknownSynergy of Exercise and Nutrition in Preventing and Treating Frailty
NCT06975540 · start 2019-10-14
Registered record
- Registry ID
- NCT06975540
- Conditions
- Frail Elderly
- Interventions
- Multidomain physical exercise
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-10-14
- Completion
- 2022-07-29
- Enrolment
- 47
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionFrail ElderlyInterventionMultidomain physical exercisePhaseNot applicableRegistry statusCompleted"Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy"
NCT07476508 · start 2019-10-10
Registered record
- Registry ID
- NCT07476508
- Conditions
- Meniscus Lesion; Knee Injuries; Medial Meniscus Tear
- Interventions
- Standard Postoperative Rehabilitation Protocol; Oral Chondroitin Sulfate (Flextrum); ntra-articular Hyaluronic Acid Injection (Biolevox)
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-10-10
- Completion
- 2022-03-31
- Enrolment
- 290
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMeniscus Lesion; Knee Injuries; Medial Meniscus TearInterventionStandard Postoperative Rehabilitation Protocol; Oral Chondroitin Sulfate (Flextrum); ntra-articular Hyaluronic Acid Injection (Biolevox)PhaseNot applicableRegistry statusCompletedVitamin D Oral Replacement in Asthma
NCT03686150 · start 2019-01-30
Registered record
- Registry ID
- NCT03686150
- Conditions
- Asthma; Vitamin D Deficiency; Pediatric Obesity
- Interventions
- Vitamin D3 oral regimen
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2019-01-30
- Completion
- 2021-09-30
- Enrolment
- 112
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAsthma; Vitamin D Deficiency; Pediatric ObesityInterventionVitamin D3 oral regimenPhaseNot applicableRegistry statusCompletedLongitudinal Effect of Vitamin D3 Replacement on Cognitive Performance and MRI Markers in Multiple Sclerosis Patients
NCT03610139 · start 2018-05-21
Registered record
- Registry ID
- NCT03610139
- Conditions
- Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Clinically Isolated Syndrome; Clinically Isolated Syndrome, CNS Demyelinating; Vitamin D3 Deficiency
- Interventions
- Vitamin D3
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2018-05-21
- Completion
- 2022-12-31
- Enrolment
- 162
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMultiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Clinically Isolated Syndrome; Clinically Isolated Syndrome, CNS Demyelinating +1 moreInterventionVitamin D3PhaseNot applicableRegistry statusUnknownEffect of Vitamin C on Collagen Production in Comparison to Hereditary Gingival Fibromatosis: Histopathological Study
NCT07043985 · start 2018-01-03
Registered record
- Registry ID
- NCT07043985
- Conditions
- Tissue Modification After Vit c Injection
- Interventions
- biopsy
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2018-01-03
- Completion
- 2025-05-06
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTissue Modification After Vit c InjectionInterventionbiopsyPhaseNot applicableRegistry statusCompletedThe Effect of Vitamin D on Fertility
NCT03890458 · start 2017-05-01
Registered record
- Registry ID
- NCT03890458
- Conditions
- Infertility; Infertility, Female; Vitamin D Deficiency; Vitamin D3 Deficiency
- Interventions
- DEVIT-3
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2017-05-01
- Completion
- 2017-11-30
- Enrolment
- 118
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInfertility; Infertility, Female; Vitamin D Deficiency; Vitamin D3 DeficiencyInterventionDEVIT-3PhasePhase 4Registry statusCompletedThe Impact of Vitamin B12 Deficiency on Infant Gut Microbiota
NCT03365583 · start 2017-03-03
Registered record
- Registry ID
- NCT03365583
- Conditions
- Vitamin B 12 Deficiency
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2017-03-03
- Completion
- 2017-11-03
- Enrolment
- 90
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin B 12 DeficiencyInterventionNot recordedPhaseNot recordedRegistry statusCompleted6 Years Study on Changes in Bone Quality, Bone Turnover and Curve Severity in AIS With and Without Calcium and Vit-D Supplementation
NCT02904421 · start 2016-10
Registered record
- Registry ID
- NCT02904421
- Conditions
- Scoliosis; Vitamin D; Bone
- Interventions
- Not recorded
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-10
- Completion
- 2019-11
- Enrolment
- 330
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionScoliosis; Vitamin D; BoneInterventionNot recordedPhaseNot recordedRegistry statusCompletedNicotinamide Riboside and Mitochondrial Metabolism
NCT03951285 · start 2016-05-25
Registered record
- Registry ID
- NCT03951285
- Conditions
- Obesity
- Interventions
- NR in BMI-discordant twins; NR in BMI-concordant twins
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2016-05-25
- Completion
- 2019-05-31
- Enrolment
- 56
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionObesityInterventionNR in BMI-discordant twins; NR in BMI-concordant twinsPhaseNot applicableRegistry statusCompletedEvaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC
NCT03047603 · start 2016-05-01
Registered record
- Registry ID
- NCT03047603
- Conditions
- Hepatocellular Carcinoma
- Interventions
- PIVKA-II
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-05-01
- Completion
- 2019-03-20
- Enrolment
- 4,005
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHepatocellular CarcinomaInterventionPIVKA-IIPhaseNot recordedRegistry statusCompletedAtrial Fibrillation Patient Preference Study
NCT02611635 · start 2016-02-02
Registered record
- Registry ID
- NCT02611635
- Conditions
- Atrial Fibrillation
- Interventions
- VKA: Warfarin (Waran); NOAC: Rivaroxaban (Xarelto, BAY59-7939); NOAC: Dabigatran etexilate; NOAC: Apixaban; NOAC: Edoxaban; NOAC: Lixiana
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2016-02-02
- Completion
- 2017-02-16
- Enrolment
- 382
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAtrial FibrillationInterventionVKA: Warfarin (Waran); NOAC: Rivaroxaban (Xarelto, BAY59-7939); NOAC: Dabigatran etexilate; NOAC: Apixaban +2 morePhaseNot recordedRegistry statusCompletedRapid Normalization of Vitamin D in Critically Ill Children: A Phase II Dose Evaluation Randomized Controlled Trial
NCT02452762 · start 2016-01
Registered record
- Registry ID
- NCT02452762
- Conditions
- Hypovitaminosis D
- Interventions
- Vitamin D3; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2016-01
- Completion
- 2018-01
- Enrolment
- 67
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHypovitaminosis DInterventionVitamin D3; PlaceboPhasePhase 2Registry statusCompletedCholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency
NCT02553447 · start 2015-10-19
Registered record
- Registry ID
- NCT02553447
- Conditions
- Chronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma; Untreated Chronic Lymphocytic Leukemia; Vitamin D Deficiency
- Interventions
- Cholecalciferol; Laboratory Biomarker Analysis
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2015-10-19
- Completion
- 2025-04-12
- Enrolment
- 197
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Lymphocytic Leukemia; Non-Hodgkin Lymphoma; Untreated Chronic Lymphocytic Leukemia; Vitamin D DeficiencyInterventionCholecalciferol; Laboratory Biomarker AnalysisPhaseNot applicableRegistry statusCompletedLong Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
NCT02774226 · start 2015-09
Registered record
- Registry ID
- NCT02774226
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Tetrahydrobiopterin (BH4); Antioxidant Cocktail
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2015-09
- Completion
- 2018-07-30
- Enrolment
- 15
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Obstructive Pulmonary Disease (COPD)InterventionTetrahydrobiopterin (BH4); Antioxidant CocktailPhasePhase 2Registry statusCompleted